KUROS BIOSCIENCES AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.24 CHF | +5.24% |
|
+15.50% | +164.76% |
| 04-24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
| 04-17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KUROS BIOSCIENCES AG | Bio Therapeutic Drugs | +5.24% | +15.50% | +164.76% | +584.44% | +298.28% | 377M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- KURN Stock
- Charts Kuros Biosciences AG
- Comparison Chart
